Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
PharmAla Biotech (MDMA.CN) Q1 2022 Earnings
MDMA.CN
31
May
Expected
Q4 2021
Q1 2022
-0
-0
-0
-0
Details
Expected EPS
N/A
Actual EPS
-0.0025
Surprise EPS
-0
Surprise Percent
+∞%
Description
PharmAla Biotech (MDMA.CN) has reported earnings of -0.0025 per share for Q1 2022.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login